Regenerative medicine company commences reverse stock split — 5 insights

Eric Oliver -   Print  |

Cesca Therapeutics commenced a one-for-10 reverse stock split of its common stock June 4.

What you should know:

1. Cesca issued one share for every 10 outstanding shares absorbed.

2. The company will not change how many shares it's authorized to issue.

3. Cesca authorized the reverse split to regain compliance with the Nasdaq's $1 minimum bid price requirement.

4. Reverse stock splits typically help companies raise the price of their shares.

5. Cesca Therapeutics creates stem cell processing technologies and autologous cell-based therapies.

More articles on devices:
Zavation receives FDA approval for new spinal fusion device — 3 insights
Indiana device company receives FDA clearance for elbow system — 3 insights
Smith & Nephew acquires orthopedic joint reconstruction business — 4 insights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers